EDITOR: NOEL GONZÁLEZ GOTERA No. 122 Sem. 24 de febrero al 2 de marzo de 2007

Publicaciones Recientes sobre Vacunas

Publicaciones incluidas en PubMED durante el período comprendido entre el 27 de enero y el 2 de febrero de 2007: documentos recuperados.

Related Articles, Links 1: Kabir S. The Current Status of Helicobacter pylori : A Review. Helicobacter. 2007 Apr;12(2):89-102. PMID: 17309745 [PubMed - in process]

Related Articles, Links 2: Xu Y, Chen A, Fry S, Barrow RA, Marshall RL, Mukkur TK. Modulation of in mice immunised with an inactivated Salmonella and gavaged with Andrographis paniculata extract or andrographolide. Int Immunopharmacol. 2007 Apr;7(4):515-23. Epub 2007 Jan 17. PMID: 17321475 [PubMed - in process]

Related Articles, Links 3: Andrews N, Stowe J, Miller E, Taylor B. Post-Licensure Safety of the Meningococcal Group C . Hum Vaccin. 2007 Mar 17;3(2) [Epub ahead of print] PMID: 17312400 [PubMed - as supplied by publisher]

Related Articles, Links 4: Yamamoto JK, Pu R, Sato E, Hohdatsu T. Feline immunodeficiency virus pathogenesis and development of a dual-subtype feline- immunodeficiency-virus vaccine. AIDS. 2007 Mar 12;21(5):547-563. No abstract available. PMID: 17314517 [PubMed - as supplied by publisher]

Simon JK, Pasetti MF, Viret JF, Mischler R, Munoz A, Lagos R, Levine Related Articles, Links 5: MM, Campbell JD. A Clinical Study to Assess the Safety and Immunogenicity of Attenuated Administered Intranasally to Healthy Adults. Hum Vaccin. 2007 Mar 10;3(2) [Epub ahead of print] PMID: 17312403 [PubMed - as supplied by publisher]

Related Articles, Links 6: Bacon DJ, Sedegah M. Reduced Production of RNA Transcripts from Individual DNA Plasmids Given in a Multivalent DNA Vaccine Formula. Hum Vaccin. 2007 Mar 9;3(2) [Epub ahead of print] PMID: 17312401 [PubMed - as supplied by publisher]

Related Articles, Links 7: Traynor K. NIH lab helps get vaccine from bench to bedside. Am J Health Syst Pharm. 2007 Mar 1;64(5):452. No abstract available. PMID: 17322152 [PubMed - in process] Related Articles, Links 8: Jing W, Orentas RJ, Johnson BD. Induction of Immunity to Neuroblastoma Early after Syngeneic Hematopoietic Stem Cell Transplantation Using a Novel Mouse Tumor Vaccine. Biol Blood Marrow Transplant. 2007 Mar;13(3):277-292. PMID: 17317581 [PubMed - as supplied by publisher]

Shin J, Wood D, Robertson J, Minor P, Peden K; on behalf of the Related Articles, Links 9: WHO Informal Consultation Group. WHO informal consultation on the application of molecular methods to assure the quality, safety and efficacy of vaccines, Geneva, Switzerland, 7-8 April 2005. Biologicals. 2007 Mar;35(1):63-71. Epub 2006 Feb 20. PMID: 17321940 [PubMed - in process]

Related Articles 10: Ames A, Gravitt P. Human papillomavirus vaccine update. Curr Infect Dis Rep. 2007 Mar;9(2):151-8. PMID: 17324353 [PubMed - in process]

Related Articles 11: Mikkelsen M, Bukh J. Current status of a : encouraging results but significant challenges ahead. Curr Infect Dis Rep. 2007 Mar;9(2):94-101. PMID: 17324345 [PubMed - in process]

Related Articles, Links 12: Crosbie EJ, Kitchener HC. --a bivalent L1 virus-like particle vaccine for prevention of human papillomavirus type 16- and 18-associated cervical . Expert Opin Biol Ther. 2007 Mar;7(3):391-6. PMID: 17309330 [PubMed - in process]

Related Articles, Links 13: Brim N, Zaller N, Taylor LE, Feller E. Twinrix schedules among injecting users. Expert Opin Biol Ther. 2007 Mar;7(3):379-89. PMID: 17309329 [PubMed - in process]

Related Articles 14: Zhang X, Wang Y, Liang H, Wei L, Xiang W, Shen R, Shao Y. Correlation between the induction of Th1 by an attenuated equine infectious anemia virus vaccine and protection against disease progression. J Gen Virol. 2007 Mar;88(Pt 3):998-1004. PMID: 17325374 [PubMed - in process]

Related Articles 15: Sun SQ, Liu XT, Guo HC, Yin SH, Shang YJ, Feng X, Liu ZX, Xie QG. Protective immune responses in guinea pigs and swine induced by a suicidal DNA vaccine of the capsid gene of swine vesicular disease virus. J Gen Virol. 2007 Mar;88(Pt 3):842-8. PMID: 17325356 [PubMed - in process]

Related Articles 16: Rosas CT, Konig P, Beer M, Dubovi EJ, Tischer BK, Osterrieder N. Evaluation of the vaccine potential of an equine herpesvirus type 1 vector expressing bovine viral diarrhea virus structural proteins. J Gen Virol. 2007 Mar;88(Pt 3):748-57. PMID: 17325347 [PubMed - in process]

Moyo S, Hawkridge T, Mahomed H, Workman L, Minnies D, Geiter Related Articles, Links 17: LJ, Verver S, Kibel M, Hussey GD. Determining causes of mortality in children enrolled in a vaccine field trial in a rural area in the Western Cape Province of South Africa. J Paediatr Child Health. 2007 Mar;43(3):178-83. PMID: 17316193 [PubMed - in process]

Related Articles, Links 18: Ford L, Lalloo DG, Hill DR. Cholera vaccines - Authors' reply. Lancet Infect Dis. 2007 Mar;7(3):178. No abstract available. PMID: 17317596 [PubMed - in process]

Related Articles, Links 19: Kabir S. Cholera vaccines. Lancet Infect Dis. 2007 Mar;7(3):176-8. No abstract available. PMID: 17317594 [PubMed - in process]

Related Articles, Links 20: [No authors listed] DCs for HIV vaccine? Nat Rev Microbiol. 2007 Mar;5(3):172. No abstract available. PMID: 17310536 [PubMed - in process]

Related Articles, Links 21: Chebolu S, Daniell H. Stable expression of Gal/GalNAc lectin of Entamoeba histolytica in transgenic chloroplasts and immunogenicity in mice towards vaccine development for amoebiasis. Plant Biotechnol J. 2007 Mar;5(2):230-9. PMID: 17309678 [PubMed - in process]

Related Articles, Links 22: Matthews K, Rhind SM, Gossner AG, Dalziel RG, Hopkins J. The Effect of Gene Gun-delivered pGM-CSF on the Immunopathology of the Vaccinated Skin. Scand J Immunol. 2007 Mar;65(3):298-307. PMID: 17309785 [PubMed - in process]

Related Articles, Links 23: Steinaa L, Rasmussen PB, Rygaard J, Mouritsen S, Gautam A. Generation of Autoreactive CTL by Tumour Vaccines Containing Foreign T Helper Epitopes. Scand J Immunol. 2007 Mar;65(3):240-8. PMID: 17309778 [PubMed - in process]

Related Articles 24: Lee ST, Neelapu SS, Kwak LW. Therapeutic vaccine for lymphoma. Yonsei Med J. 2007 Feb 28;48(1):1-10. PMID: 17326239 [PubMed - in process]

Prichard MN, Keith KA, Johnson MP, Harden EA, McBrayer A, Luo M, Qiu S, Related Articles 25: Chattopadhyay D, Fan X, Torrence PF, Kern ER. Selective Phosphorylation of Antiviral by Vaccinia Virus Thymidine Kinase. Antimicrob Agents Chemother. 2007 Feb 26; [Epub ahead of print] PMID: 17325220 [PubMed - as supplied by publisher] Rollier CS, Paranhos-Baccala G, Verschoor EJ, Verstrepen BE, Drexhage Related Articles 26: JA, Fagrouch Z, Berland JL, Komurian-Pradel F, Duverger B, Himoudi N, Staib C, Meyr M, Whelan M, Whelan JA, Adams VA, Larrea E, Riezu JI, Lasarte JJ, Bartosch B, Cosset FL, Spaan WJ, Diepolder HM, Pape GR, Sutter G, Inchauspe G, Heeney JL. Vaccine-induced early control of hepatitis C virus in chimpanzees fails to impact on hepatic PD-1 and chronicity. Hepatology. 2007 Feb 26;45(3):602-613 [Epub ahead of print] PMID: 17326154 [PubMed - as supplied by publisher]

Related Articles 27: Tanghe A, Adnet PY, Gartner T, Huygen K. A booster vaccination with M. bovis BCG does not increase the protective effect of the vaccine against experimental ulcerans infection in mice. Infect Immun. 2007 Feb 26; [Epub ahead of print] PMID: 17325046 [PubMed - as supplied by publisher]

Yamano T, Kaneda Y, Hiramatsu SH, Huang S, Tran AN, Giuliano Related Articles, Links 28: AE, Hoon DS. Immunity against breast cancer by TERT DNA vaccine primed with CCL21. Cancer Gene Ther. 2007 Feb 23; [Epub ahead of print] PMID: 17318199 [PubMed - as supplied by publisher]

Related Articles, Links 29: Chakraborty M, Schlom J, Hodge JW. The combined activation of positive costimulatory signals with modulation of a negative costimulatory signal for the enhancement of vaccine-mediated T-cell responses. Cancer Immunol Immunother. 2007 Feb 23; [Epub ahead of print] PMID: 17318654 [PubMed - as supplied by publisher]

Tacke F, Amini-Bavil-Olyaee S, Heim A, Luedde T, Manns MP, Trautwein Related Articles 30: C. Acute hepatitis B virus infection by genotype F despite successful vaccination in an immune-competent German patient. J Clin Virol. 2007 Feb 23; [Epub ahead of print] PMID: 17324621 [PubMed - as supplied by publisher]

Related Articles, Links 31: Liska V, Bigert SA, Bennett PS, Olsen D, Chang R, Burke CJ. Evaluation of a recombinant human gelatin as a substitute for a hydrolyzed porcine gelatin in a refrigerator-stable Oka/Merck live . J Immune Based Ther Vaccines. 2007 Feb 23;5(1):4 [Epub ahead of print] PMID: 17319952 [PubMed - as supplied by publisher]

Related Articles 32: Dempsey AF, Koutsky LA, Golden M. Potential Impact of Human Papillomavirus Vaccines on Public STD Clinic Workloads and on Opportunities to Diagnose and Treat Other Sexually Transmitted Diseases. Sex Transm Dis. 2007 Feb 23; [Epub ahead of print] PMID: 17325621 [PubMed - as supplied by publisher]

Related Articles, Links 33: Kallenius G, Pawlowski A, Brandtzaeg P, Svenson S. Should a new vaccine be administered intranasally? Tuberculosis (Edinb). 2007 Feb 23; [Epub ahead of print] PMID: 17321797 [PubMed - as supplied by publisher]

Related Articles, Links 34: [No authors listed] --update. Wkly Epidemiol Rec. 2007 Feb 23;82(8):62-8. English, French. No abstract available. PMID: 17319033 [PubMed - indexed for MEDLINE]

Related Articles, Links 35: Soysal A, Gokce I, Pehlivan T, Bakir M. Interchangeability of a second dose: Avaxim 80 following a first dose of Vaqta 25 or Havrix 720 in children in Turkey. Eur J Pediatr. 2007 Feb 22; [Epub ahead of print] PMID: 17318620 [PubMed - as supplied by publisher]

Related Articles, Links 36: Nishiura H, Eichner M. Interpreting the of postexposure vaccination against smallpox. Int J Hyg Environ Health. 2007 Feb 22; [Epub ahead of print] PMID: 17321212 [PubMed - as supplied by publisher]

Related Articles, Links 37: Muhamuda K, Madhusudana SN, Ravi V. Development and evaluation of a competitive ELISA for estimation of rabies neutralizing after post-exposure rabies vaccination in humans. Int J Infect Dis. 2007 Feb 22; [Epub ahead of print] PMID: 17321182 [PubMed - as supplied by publisher]

Tavel JA, Martin JE, Kelly GG, Enama ME, Shen JM, Gomez PL, Andrews Related Articles 38: CA, Koup RA, Bailer RT, Stein JA, Roederer M, Nabel GJ, Graham BS; and the Vaccine Research Center 001 Study Team. Safety and Immunogenicity of a Gag-Pol Candidate HIV-1 DNA Vaccine Administered by a Needle-Free Device in HIV-1-Seronegative Subjects. J Acquir Immune Defic Syndr. 2007 Feb 22; [Epub ahead of print] PMID: 17325604 [PubMed - as supplied by publisher]

Related Articles, Links 39: Lim SY, Meyer M, Kjonaas RA, Ghosh SK. Correction: Phytol-based novel adjuvants in vaccine formulation: 1. assessment of safety and efficacy during stimulation of humoral and cell-mediated immune responses. J Immune Based Ther Vaccines. 2007 Feb 22;5(1):3 [Epub ahead of print] PMID: 17316445 [PubMed - as supplied by publisher]

Related Articles, Links 40: Bauer T, Gunther M, Bienzle U, Neuhaus R, Jilg W. Vaccination against hepatitis B in liver transplant recipients: Pilot analysis of cellular immune response shows evidence of HBsAg-specific regulatory T cells. Liver Transpl. 2007 Feb 22;13(3):434-442 [Epub ahead of print] PMID: 17318860 [PubMed - as supplied by publisher]

Rosenau J, Hooman N, Hadem J, Rifai K, Bahr MJ, Philipp G, Related Articles, Links 41: Tillmann HL, Klempnauer J, Strassburg CP, Manns MP. Failure of hepatitis B vaccination with conventional HBsAg vaccine in patients with continuous HBIG prophylaxis after liver transplantation. Liver Transpl. 2007 Feb 22;13(3):367-373 [Epub ahead of print] PMID: 17318859 [PubMed - as supplied by publisher]

Related Articles, Links 42: Dilaveris D, Chen C, Kaiser P, Russell PH. The safety and immunogenicity of an in ovo vaccine against Newcastle disease virus differ between two lines of chicken. Vaccine. 2007 Feb 22; [Epub ahead of print] PMID: 17321645 [PubMed - as supplied by publisher] Related Articles, Links 43: Nichols JR, Stovall SH, Jacobs RF. Human Papillomavirus Infection: The Role of Vaccination in Pediatric Patients. Clin Pharmacol Ther. 2007 Feb 21; [Epub ahead of print] PMID: 17314926 [PubMed - as supplied by publisher]

Related Articles, Links 44: Kim KH, Greenfield W, Shotts E, Nakagawa M. Detection of Human Papillomavirus Type 16-Specific T Using a Recombinant Vaccinia Virus-Based ELISPOT Assay. Clin Vaccine Immunol. 2007 Feb 21; [Epub ahead of print] PMID: 17314231 [PubMed - as supplied by publisher]

Related Articles, Links 45: Gross G. HPV-vaccination against cervical carcinoma: will it really work? Med Microbiol Immunol. 2007 Feb 21; [Epub ahead of print] PMID: 17318575 [PubMed - as supplied by publisher]

Esposito S, Lizioli A, Lastrico A, Begliatti E, Rognoni A, Tagliabue C, Related Articles, Links 46: Cesati L, Carreri V, Principi N. Impact on respiratory tract of heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 11 months of age. Respir Res. 2007 Feb 21;8:12. PMID: 17313667 [PubMed - in process]

Handisurya A, Gilch S, Winter D, Shafti-Keramat S, Maurer D, Related Articles, Links 47: Schatzl HM, Kirnbauer R. Vaccination with prion peptide-displaying papillomavirus-like particles induces autoantibodies to normal prion protein that interfere with pathologic prion protein production in infected cells. FEBS J. 2007 Feb 20; [Epub ahead of print] PMID: 17313482 [PubMed - as supplied by publisher]

Related Articles, Links 48: Griffin KF, Oyston PC, Titball RW. Francisella tularensis vaccines. FEMS Immunol Med Microbiol. 2007 Feb 20; [Epub ahead of print] PMID: 17316369 [PubMed - as supplied by publisher]

Hatzfeld-Charbonnier AS, Lasek A, Castera L, Gosset P, Velu T, Related Articles, Links 49: Formstecher P, Mortier L, Marchetti P. Influence of heat stress on human monocyte-derived functions with immunotherapeutic potential for antitumor vaccines. J Leukoc Biol. 2007 Feb 20; [Epub ahead of print] PMID: 17311933 [PubMed - as supplied by publisher]

Related Articles, Links 50: Lansac J, Rouzier R, Riethmuller D, Leveque J. [Should we vaccinate our daughters against cervical cancer?] J Gynecol Obstet Biol Reprod (Paris). 2007 Feb 19; [Epub ahead of print] French. No abstract available. PMID: 17317034 [PubMed - as supplied by publisher]

Related Articles, Links 51: Bull AL, Bennett N, Pitcher HC, Russo PL, Richards MJ. coverage among health care workers in Victorian public hospitals. Med J Aust. 2007 Feb 19;186(4):185-6. PMID: 17309419 [PubMed - in process] Related Articles, Links 52: Marmion B. : the long journey to control by vaccination. Med J Aust. 2007 Feb 19;186(4):164-6. PMID: 17309414 [PubMed - in process]

Related Articles, Links 53: Gupta UD, Katoch VM, McMurray DN. Current status of TB vaccines. Vaccine. 2007 Feb 16; [Epub ahead of print] PMID: 17321015 [PubMed - as supplied by publisher]

Martins MA, Silva ML, Marciano AP, Peruhype-Magalhaes V, Eloi- Related Articles, Links 54: Santos SM, Ribeiro JG, Correa-Oliveira R, Homma A, Kroon EG, Teixeira-Carvalho A, Martins-Filho OA. Activation/modulation of adaptive immunity emerges simultaneously after 17DD yellow fever first-time vaccination: is this the key to prevent severe adverse reactions following ? Clin Exp Immunol. 2007 Feb 15; [Epub ahead of print] PMID: 17309541 [PubMed - as supplied by publisher]

Dubey S, Clair J, Fu TM, Guan L, Long R, Mogg R, Anderson K, Related Articles, Links 55: Collins KB, Gaunt C, Fernandez VR, Zhu L, Kierstead L, Thaler S, Gupta SB, Straus W, Mehrotra D, Tobery TW, Casimiro DR, Shiver JW. Detection of HIV Vaccine-Induced Cell-Mediated Immunity in HIV-Seronegative Participants Using an Optimized and Validated Enzyme-Linked Immunospot Assay. J Acquir Immune Defic Syndr. 2007 Feb 15; [Epub ahead of print] PMID: 17310936 [PubMed - as supplied by publisher]

Yanagimoto H, Mine T, Yamamoto K, Satoi S, Terakawa N, Related Articles, Links 56: Takahashi K, Nakahara K, Honma S, Tanaka M, Mizoguchi J, Yamada A, Oka M, Kamiyama Y, Itoh K, Takai S. Immunological evaluation of personalized peptide vaccination with gemcitabine for pancreatic cancer. Cancer Sci. 2007 Feb 12; [Epub ahead of print] PMID: 17309598 [PubMed - as supplied by publisher]

Related Articles, Links 57: Dennehy PH. Rotavirus vaccines-An update. Vaccine. 2007 Feb 9; [Epub ahead of print] PMID: 17321017 [PubMed - as supplied by publisher]

Related Articles, Links 58: Danova J, Gopfertova D, Bobak M. Rates of contraindications and use of alternative vaccines in routine immunisation of children: A population based study in the Czech Republic. Vaccine. 2007 Feb 8; [Epub ahead of print] PMID: 17316928 [PubMed - as supplied by publisher]

Related Articles, Links 59: Booy R, Jelfs J, El Bashir H, Nissen MD. Impact of meningococcal C conjugate vaccine use in Australia. Med J Aust. 2007 Feb 5;186(3):108-9. No abstract available. PMID: 17309394 [PubMed - in process]

Khan MA, Ferro VA, Koyama S, Kinugasa Y, Song M, Ogita K, Related Articles, Links 60: Tsutsui T, Murata Y, Kimura T. Immunisation of male mice with a plasmid DNA vaccine encoding gonadotrophin releasing hormone (GnRH-I) and T-helper epitopes suppresses fertility in vivo. Vaccine. 2007 Feb 5; [Epub ahead of print] PMID: 17316929 [PubMed - as supplied by publisher]

Related Articles 61: Centers for Disease Control and Prevention. Influenza vaccination rates for nurses need a boost. AAOHN J. 2007 Feb;55(2):88. No abstract available. PMID: 17323874 [PubMed - in process]

Du X, Zheng G, Jin H, Kang Y, Wang J, Xiao C, Zhang S, Zhao L, Related Articles, Links 62: Chen A, Wang B. The adjuvant effects of co-stimulatory molecules on cellular and memory responses to HBsAg DNA vaccination. J Gene Med. 2007 Feb;9(2):136-46. PMID: 17310492 [PubMed - in process]

Maggio R, Peragine N, Calabrese E, De Propris MS, Intoppa S, Della Starza Related Articles 63: I, Ariola C, Vitale A, Foa R, Guarini A. Generation of functional dendritic cells (DC) in adult acute lymphoblastic leukemia: rationale for a DC-based vaccination program for patients in complete hematological remission. Leuk Lymphoma. 2007 Feb;48(2):302-310. PMID: 17325890 [PubMed - as supplied by publisher]

Related Articles, Links 64: [No authors listed] Cancer vaccines. Closing in on the next frontier. Mayo Clin Health Lett. 2007 Feb;25(2):4-5. No abstract available. PMID: 17323442 [PubMed - indexed for MEDLINE]

Cheng C, Gall JG, Kong WP, Sheets RL, Gomez PL, King CR, Nabel Related Articles, Links 65: GJ. Mechanism of ad5 vaccine immunity and toxicity: fiber shaft targeting of dendritic cells. PLoS Pathog. 2007 Feb;3(2):e25. PMID: 17319743 [PubMed - in process]

Gubser C, Bergamaschi D, Hollinshead M, Lu X, van Kuppeveld FJ, Related Articles, Links 66: Smith GL. A new inhibitor of apoptosis from vaccinia virus and eukaryotes. PLoS Pathog. 2007 Feb;3(2):e17. PMID: 17319741 [PubMed - in process]

Related Articles 67: [No authors listed] Oseltamivir: new indication. Prevention of influenza in at-risk children: vaccination is best. Prescrire Int. 2007 Feb;16(87):9-11. PMID: 17323516 [PubMed - in process]

Related Articles 68: [No authors listed] Rotavirus vaccines: new drug. Rotavirus infection: one case of severe diarrhoea prevented per 100 vaccinated infants. Prescrire Int. 2007 Feb;16(87):3-6. PMID: 17323513 [PubMed - in process]

Related Articles 69: Barocchi MA, Censini S, Rappuoli R. Vaccines in the era of genomics: The pneumococcal challenge. Vaccine. 2007 Jan 30; [Epub ahead of print] PMID: 17324490 [PubMed - as supplied by publisher]

Related Articles, Links 70: Fernandes GC, Camacho LA, Carvalho MS, Batista M, Almeida SM. Neurological adverse events temporally associated to mass vaccination against yellow fever in Juiz de Fora, Brazil, 1999-2005. Vaccine. 2007 Jan 30; [Epub ahead of print] PMID: 17316927 [PubMed - as supplied by publisher]

Related Articles, Links 71: Devlin JM, Browning GF, Hartley CA, Gilkerson JR. Glycoprotein G deficient infectious laryngotracheitis virus is a candidate . Vaccine. 2007 Jan 30; [Epub ahead of print] PMID: 17316926 [PubMed - as supplied by publisher]

Navas E, Salleras L, Dominguez A, Ibanez D, Prat A, Sentis A, Garrido P, Related Articles 72: Plasencia A. Cost-effectiveness analysis of inactivated virosomal subunit influenza vaccination in children aged 3-14 years from the provider and societal perspectives. Vaccine. 2007 Jan 25; [Epub ahead of print] PMID: 17324489 [PubMed - as supplied by publisher]

Waller A, Flock M, Smith K, Robinson C, Mitchell Z, Karlstrom A, Related Articles, Links 73: Lannergard J, Bergman R, Guss B, Flock JI. Vaccination of horses against strangles using recombinant from Streptococcus equi. Vaccine. 2007 Jan 22; [Epub ahead of print] PMID: 17321016 [PubMed - as supplied by publisher]

Borras E, Dominguez A, Batalla J, Torner N, Cardenosa N, Nebot M, Related Articles, Links 74: Plasencia A, Salleras L. Vaccination coverage in indigenous and immigrant children under 3 years of age in Catalonia (Spain). Vaccine. 2007 Jan 22; [Epub ahead of print] PMID: 17320249 [PubMed - as supplied by publisher]

Collaborative Group for Studies with . Related Articles, Links 75: Randomized, double-blind, multicenter study of the immunogenicity and reactogenicity of 17DD and WHO 17D-213/77 yellow fever vaccines in children: Implications for the Brazilian National Immunization Program. Vaccine. 2007 Jan 22; [Epub ahead of print] PMID: 17316925 [PubMed - as supplied by publisher]

Streefland M, van de Waterbeemd B, Happe H, van der Pol LA, Related Articles, Links 76: Beuvery EC, Tramper J, Martens DE. PAT for vaccines: The first stage of PAT implementation for development of a well-defined whole-cell vaccine against whooping cough disease. Vaccine. 2007 Jan 22; [Epub ahead of print] PMID: 17313999 [PubMed - as supplied by publisher]

Related Articles, Links 77: Hamidi M, Zarei N, Zarrin AH, Mohammadi-Samani S. Preparation and in vitro characterization of carrier erythrocytes for vaccine delivery. Int J Pharm. 2007 Jan 20; [Epub ahead of print] PMID: 17317049 [PubMed - as supplied by publisher] Related Articles, Links 78: Kurstak E. New vaccines development, immunisation and immunotherapy. Vaccine. 2007 Jan 16; [Epub ahead of print] No abstract available. PMID: 17316930 [PubMed - as supplied by publisher]

Related Articles, Links 79: Gopinathan L, Kirimanjeswara GS, Wolfe DN, Kelley ML, Harvill ET. Different mechanisms of vaccine-induced and infection-induced immunity to Bordetella bronchiseptica. Microbes Infect. 2007 Jan 12; [Epub ahead of print] PMID: 17317263 [PubMed - as supplied by publisher]

Related Articles, Links 80: Woodhouse A, Dickson TC, Vickers JC. Vaccination strategies for Alzheimer's disease : a new hope? Drugs Aging. 2007;24(2):107-19. PMID: 17313199 [PubMed - in process]

Related Articles, Links 81: Horrigan BJ. Exposure to polychlorinated biphenyls may reduce the effectiveness of vaccines in children. Explore (NY). 2007 Jan-Feb;3(1):7-8. No abstract available. PMID: 17315328 [PubMed - in process]

Related Articles, Links 82: Smith SZ. Flu vaccine politics. J Ky Med Assoc. 2007 Jan;105(1):29. No abstract available. PMID: 17310876 [PubMed - in process]

Related Articles, Links 83: Van Gilder D. Two new vaccines: and Rotateq. S D Med. 2007 Jan;60(1):13-4. No abstract available. PMID: 17319292 [PubMed - in process]

Cai YG, Fang DC, Chen L, Wang DX, Luo YH, Tang XD, Chen T, Related Articles, Links 84: Yang SM. [Immune response of heparanase gene modified dendritic cell-based vaccine on gastric cancer cells] Zhonghua Yi Xue Za Zhi. 2006 Nov 28;86(44):3122-7. Chinese. PMID: 17313764 [PubMed - in process]

Huang XG, Xu JQ, Ren L, Qiu C, Zhang N, Liu LX, Wan YM, Peng H, Related Articles, Links 85: Shao YM. [Intranasal priming with HIV DNA vaccine and systemic boosting with recombinant vaccinia induce vigorous immune responses: experiment with mice] Zhonghua Yi Xue Za Zhi. 2006 Nov 28;86(44):3109-13. Chinese. PMID: 17313761 [PubMed - in process]

Dos Santos BA, Stralioto SM, Siqueira MM, Ranieri TS, Bercini M, Related Articles, Links 86: Schermann MT, Wagner MB, Silveira TR. Prevalence of antibodies against measles, mumps, and rubella before and after vaccination of school-age children with three different triple combined viral vaccines, Rio Grande do Sul, Brazil, 1996. Rev Panam Salud Publica. 2006 Nov;20(5):299-306. PMID: 17316487 [PubMed - as supplied by publisher] Related Articles 87: Liao F, He C, Liu HP, Song QF, Yan J. [Construction of the DNA vaccine of major outer membrane protein of Neisseria gonorrhoeae and investigation of immune effects after vaccination] Zhonghua Yu Fang Yi Xue Za Zhi. 2006 Nov;40(6):422-6. Chinese. PMID: 17313744 [PubMed - in process]

Related Articles, Links 88: Alvis Guzman N, De La Hoz Restrepo F, Vivas Consuelo D. [The cost-effectiveness of Haemophilus influenzae type b vaccine for children under 2 years of age in Colombia.] Rev Panam Salud Publica. 2006 Oct;20(4):248-55. Spanish. PMID: 17316483 [PubMed - in process]

Constenla D, Perez-Schael I, Rheingans RD, Antil L, Salas H, Related Articles, Links 89: Yarzabal JP. [Assessment of the economic impact of the antiretroviral vaccine in Venezuela.] Rev Panam Salud Publica. 2006 Oct;20(4):213-22. Spanish. PMID: 17316479 [PubMed - in process]

Related Articles, Links 90: Stephenson JR. Developing vaccines against flavivirus diseases: past success, present hopes and future challenges. Novartis Found Symp. 2006;277:193-201; discussion 201-5, 251-3. PMID: 17319163 [PubMed - in process]

Related Articles, Links 91: Lyda RO, Hall JR, Kirkpatrick JF. A comparison of Freund's Complete and Freund's Modified Adjuvants used with a contraceptive vaccine in wild horses (Equus caballus). J Zoo Wildl Med. 2005 Dec;36(4):610-6. PMID: 17312717 [PubMed - in process]

Related Articles 92: Coke RL, Backues KA, Hoover JP, Saliki JT, Ritchey JW, West GD. Serologic responses after vaccination of fennec foxes (Vulpes zerda) and meerkats (Suricata suricatta) with a live, canarypox-vectored canine distemper virus vaccine. J Zoo Wildl Med. 2005 Jun;36(2):326-30. PMID: 17323579 [PubMed - in process]

Related Articles 93: Johnson S. Avian titer development against West nile virus after extralabel use of an equine vaccine. J Zoo Wildl Med. 2005 Jun;36(2):257-64. PMID: 17323567 [PubMed - in process]

Related Articles 94: Blasier MW, Travis DA, Barbiers R. Retrospective evaluation of measles titers in vaccinated captive gorillas (Gorilla gorilla gorilla). J Zoo Wildl Med. 2005 Jun;36(2):198-203. PMID: 17323559 [PubMed - in process]

Related Articles, Links 95: McLelland DJ, Kirkland PD, Rose KA, Dixon RJ, Smith N. Serologic responses of Barbary sheep (Ammotragus lervia), Indian antelope (Antilope cervicapra), wallaroos (Macropus robustus), and chimpanzees (Pan troglodytes) to an inactivated encephalomyocarditis virus vaccine. J Zoo Wildl Med. 2005 Mar;36(1):69-73. PMID: 17315459 [PubMed - in process]

Related Articles, Links 96: Al-Hajjar S. Vaccines in the new millennium. Ann Saudi Med. 2000 May-July;20(3-4):194-6. No abstract available. PMID: 17322655 [PubMed - in process]

Related Articles, Links 97: Khalil M, Al-Mazrou Y, Al-Howasi M, Al-Jeffri M, Al-Ghamdy Y. Follow-up of Saudi children vaccinated with Haemophilus influenzae type B vaccine. Ann Saudi Med. 2000 Mar;20(2):122-4. PMID: 17322707 [PubMed - in process]

AMEDEO - Vaccines (28 – 02 - 2007 ): 26 artículos nuevos.

1. YAMAMOTO JK, Pu R, Sato E, Hohdatsu T, et al. Feline immunodeficiency virus pathogenesis and development of a dual-subtype feline-immunodeficiency-virus vaccine. AIDS. 2007;21:547-563. http://amedeo.com/p2.php?id=17314517&s=vac

2. COLE A. Governments unite to fund vaccine for poor countries. BMJ. 2007;334:335. http://amedeo.com/p2.php?id=17303862&s=vac

3. TANNE JH. Texas governor is criticised for decision to vaccinate all girls against HPV. BMJ. 2007;334:332-3. http://amedeo.com/p2.php?id=17303856&s=vac

4. STEWART VA, McGrath SM, Dubois PM, Pau MG, et al. Priming with an Adenovirus 35-CS vaccine followed by RTS,S/AS01B boosting significantly improves immunogenicity to P. falciparum CS over either vaccine alone. Infect Immun. 2007;. http://amedeo.com/p2.php?id=17307942&s=vac ABSTRACT available

5. WARFIELD KL, Blutt SE, Crawford SE, Kang G, et al. Rotavirus infection enhances lipopolysaccharide-induced intussusception in a mouse model. J Virol. 2006;80:12377-86. http://amedeo.com/p2.php?id=17005639&s=vac ABSTRACT available

6. KURSTAK E. New vaccines development, immunisation and immunotherapy. Vaccine. 2007;. http://amedeo.com/p2.php?id=17316930&s=vac

7. KHAN MA, Ferro VA, Koyama S, Kinugasa Y, et al. Immunisation of male mice with a plasmid DNA vaccine encoding gonadotrophin releasing hormone (GnRH-I) and T-helper epitopes suppresses fertility in vivo. Vaccine. 2007;. http://amedeo.com/p2.php?id=17316929&s=vac ABSTRACT available

8. DANOVA J, Gopfertova D, Bobak M. Rates of contraindications and use of alternative vaccines in routine immunisation of children: A population based study in the Czech Republic. Vaccine. 2007;. http://amedeo.com/p2.php?id=17316928&s=vac ABSTRACT available

9. FERNANDES GC, Camacho LA, Carvalho MS, Batista M, et al. Neurological adverse events temporally associated to mass vaccination against yellow fever in Juiz de Fora, Brazil, 1999-2005. Vaccine. 2007;. http://amedeo.com/p2.php?id=17316927&s=vac ABSTRACT available

10. DEVLIN JM, Browning GF, Hartley CA, Gilkerson JR, et al. Glycoprotein G deficient infectious laryngotracheitis virus is a candidate attenuated vaccine. Vaccine. 2007;. http://amedeo.com/p2.php?id=17316926&s=vac ABSTRACT available

11. Randomized, double-blind, multicenter study of the immunogenicity and reactogenicity of 17DD and WHO 17D-213/77 yellow fever vaccines in children: Implications for the Brazilian National Immunization Program. Vaccine. 2007;. http://amedeo.com/p2.php?id=17316925&s=vac ABSTRACT available

12. STREEFLAND M, van de Waterbeemd B, Happe H, van der Pol LA, et al. PAT for vaccines: The first stage of PAT implementation for development of a well-defined whole-cell vaccine against whooping cough disease. Vaccine. 2007;. http://amedeo.com/p2.php?id=17313999&s=vac ABSTRACT available

13. JACKSON Y, Chappuis F, Mezger N, Kanappa K, et al. High immunogenicity of delayed third dose of in travellers. Vaccine. 2007;. http://amedeo.com/p2.php?id=17306910&s=vac ABSTRACT available

14. LADDY DJ, Yan J, Corbitt N, Kobasa D, et al. Immunogenicity of novel consensus-based DNA vaccines against . Vaccine. 2007;. http://amedeo.com/p2.php?id=17306909&s=vac ABSTRACT available

15. ZHOU F, Shefer A, Weinbaum C, McCauley M, et al. Impact of hepatitis A vaccination on health care utilization in the United States, 1996-2004. Vaccine. 2007;. http://amedeo.com/p2.php?id=17306908&s=vac ABSTRACT available

16. WILSON JN, Nokes DJ, Medley GF, Shouval D, et al. Mathematical model of the antibody response to hepatitis B vaccines: Implications for reduced schedules. Vaccine. 2007;. http://amedeo.com/p2.php?id=17306427&s=vac ABSTRACT available

17. RUSSO TA, Beanan JM, Olson R, Genagon SA, et al. A killed, genetically engineered derivative of a wild-type extraintestinal pathogenic E. coli strain is a vaccine candidate. Vaccine. 2007;. http://amedeo.com/p2.php?id=17306426&s=vac ABSTRACT available

18. MONZAVI-KARBASSI B, Hennings LJ, Artaud C, Liu T, et al. Preclinical studies of carbohydrate mimetic peptide vaccines for breast cancer and melanoma. Vaccine. 2007;. http://amedeo.com/p2.php?id=17303294&s=vac ABSTRACT available

19. ZUNIGA A, Wang Z, Liniger M, Hangartner L, et al. Attenuated measles virus as a vaccine vector. Vaccine. 2007;. http://amedeo.com/p2.php?id=17303293&s=vac ABSTRACT available

20. ZHANG X, Zhang X, Yang Q. Effect of compound mucosal immune adjuvant on mucosal and systemic immune responses in chicken orally vaccinated with attenuated Newcastle-disease vaccine. Vaccine. 2007;. http://amedeo.com/p2.php?id=17303292&s=vac ABSTRACT available

21. DUC LE H, Hong HA, Atkins HS, Flick-Smith HC, et al. Immunization against anthrax using Bacillus subtilis spores expressing the anthrax protective . Vaccine. 2007;25:346-55. http://amedeo.com/p2.php?id=17007969&s=vac ABSTRACT available

22. TAMMIRUUSU A, Penttila T, Lahesmaa R, Sarvas M, et al. Intranasal administration of chlamydial outer protein N (CopN) induces protection against pulmonary Chlamydia pneumoniae infection in a mouse model. Vaccine. 2007;25:283-90. http://amedeo.com/p2.php?id=16949182&s=vac ABSTRACT available

23. TOZZI AE, Pandolfi E, Celentano LP, Massari M, et al. Comparison of pertussis surveillance systems in Europe. Vaccine. 2007;25:291-7. http://amedeo.com/p2.php?id=16920230&s=vac ABSTRACT available

24. LANTERMANN M, Schwantes A, Sliva K, Sutter G, et al. Vaccinia virus double-stranded RNA- binding protein E3 does not interfere with siRNA-mediated gene silencing in mammalian cells. Virus Res. 2007;. http://amedeo.com/p2.php?id=17306404&s=vac ABSTRACT available

25. Outbreak news. Yellow fever, Togo--update. Wkly Epidemiol Rec. 2007;82:50. http://amedeo.com/p2.php?id=17310514&s=vac

26. Mumps virus vaccines. Wkly Epidemiol Rec. 2007;82:51-60. http://amedeo.com/p2.php?id=17304707&s=vac

Otras Noticias sobre Vacunas e Inmunizaciones.

Toll like receptor-3 ligand poly-ICLC promotes the efficacy of peripheral with tumor antigen-derived peptide epitopes in murine CNS tumor models... Xinmei Zhu, et al. - These data suggest that poly-ICLC, which has been previously evaluated in clinical trials, can be effectively combined with tumor Ag-specific vaccine strategies, thereby providing a greater index of therapeutic efficacy... BMC , 02/26/07. Free Full Text View Article Save Article Email Article

Immunotherapy of Tumors with Neuroimmune Ligand Capsaicin Jacqueline Beltran, et al. - Red chili pepper (Capsicum frutescens) is a highly consumed spice throughout the world. Its principal pungent ingredient is the phenol capsaicin (8-methyl-N-vanillyl-6-nonenamide). Capsaicin causes neurogenic inflammation and has analgesic and anti-inflammatory activities... Journal of Immunology, 02/26/07 View Article Save Article Email Article

Toll like receptor-3 ligand poly-ICLC promotes the efficacy of peripheral vaccinations with tumor antigen-derived peptide epitopes in murine CNS tumor models... Xinmei Zhu, et al. - These data suggest that poly-ICLC, which has been previously evaluated in clinical trials, can be effectively combined with tumor Ag-specific vaccine strategies, thereby providing a greater index of therapeutic efficacy... BMC Immunology, 02/26/07 Free Full Text View Article Save Article Email Article

Possible therapeutic vaccines for canine myasthenia gravis: Implications for the human disease and associated fatigue... F. Shawn Galin, et al. - These results are suggestive of a new type of targeted therapy that can drive autoimmune responses into long-term remission and possibly afford a means of determining whether correction of a physical cause of muscle weakness also corrects the perception of chronic, generalized fatigue... Brain, Behavior, and Immunity, 02/20/07 View Article Save Article Email Article

Inactivated and Live Attenuated Influenza Vaccines in Young Children - How Do They Compare? Nancy J. Cox, Ph.D., et al. - Two quite different influenza vaccines are now licensed for use in the United States - a trivalent inactivated influenza vaccine that is administered intramuscularly and a live attenuated influenza vaccine that is administered by means of a nasal spray. The trivalent was first licensed for use in military populations during the 1940s... New England Journal of Medicine, 02/16/07 View Article Save Article Email Article

Improving Influenza Vaccine Compliance Through Patient Education for Patients With Cystic Fibrosis Catherine Tran RN, MS., et al. - Complications from chronic lung disease are the leading cause of mortality in the CF population. Standardization of care and additional CF therapies are factors in the improvement of the length and quality of life for patients with CF. According to the Cystic Fibrosis Foundation Clinical Practice Guidelines (1997), all patients with CF older than 6 months of age should receive the influenza vaccine annually... Journal of Pediatric Health Care, 02/27/07 View Article Save Article Email Article

Suitability of vaccinia virus and bovine viral diarrhea virus (BVDV) for determining activities of three commonly-used alcohol-based hand rubs against enveloped viruses... Gunter Kampf, et al. - Commonly used alcohol-based hand rubs with a total alcohol concentration >= 75% can be assumed to be active against clinically relevant enveloped viruses if they effectively reduce the infectivities of vaccinia virus and BVDV in a quantitative suspension test... BMC Infectious Diseases, 02/23/07 Free Full Text View Article Save Article Email Article

UNITED STATES PATENT AND TRADEMARK OFFICE (USPTO).

(ABST/vaccine AND ISD/2007021->20070302): 3 patentes recuperadas.

PAT. NO. Title 1 7,183,404 Vaccine against ISA virus 2 7,182,947 Papillomavirus truncated L1 protein and constructs 3 RE39,494 Inactivated mycoplasma hyopneumoniae and uses therefor

EUROPEAN PATENT OFFICE (EPO) Resultados de febrero de 2007 .

Estrategia de búsqueda: “ vaccine” en Título y Abstract: 66 patentes recuperadas.

1 Group B streptococcus antigens in my patents list Inventor: BRODEUR BERNARD R (CA); RIOUX Applicant: ID BIOMEDICAL CORP (CA)

CLEMENT (CA); (+4) EC: C07K14/315 IPC: C12N15/09; C12N15/31; A61K39/09 (+17)

Publication info: EP1757697 - 2007-02-28

2 LIVE, ORAL VACCINE FOR PROTECTION AGAINST SHIGELLA DYSENTERIAE SEROTYPE 1 in my patents list Inventor: KOPECKO DENNIS J (US); XU DEQI (US) Applicant: US GOVERNMENT (US)

EC: C07K14/25; C12N15/52 IPC: C07K14/25; A61K39/112; C07K14/195 (+1)

Publication info: EP1756149 - 2007-02-28

VACCINE COMPOSITIONS COMPRISING VIROSOMES AND A SAPONIN ADJUVANT 3 in my patents list Inventor: COLLER BETH-ANN (BE); HENDERICKX Applicant: GLAXOSMITHKLINE BIOLOG SA (BE)

VERONIQUE (BE); (+1) EC: A61K39/145; A61K39/39; (+1) IPC: A61K39/145; A61K9/127; A61K39/39 (+9)

Publication info: EP1755666 - 2007-02-28

MAGE-3 AND NY-ESO-1 BASED POLYVALENT VACCINE FOR CANCER 4 IMMUNOTHERAPY in my patents list Inventor: BRUCK CLAUDINE ELVIRE MARIE (US); Applicant: GLAXOSMITHKLINE BIOLOG SA (BE)

BRICHARD VINCENT (BE); (+2) EC: A61K39/00D6 IPC: A61K39/00; A61K39/00

Publication info: EP1755657 - 2007-02-28

ANTI-OBESE IMMUNOGENIC HYBRID POLYPEPTIDES AND ANTI-OBESE VACCINE 5 COMPOSITION COMPRISING THE SAME in my patents list Inventor: KIM HYO-JOON (KR) Applicant: SJ BIOMED INC (KR)

EC: C07K14/775 IPC: C07K14/00; C07K14/705; C07K14/775 (+2)

Publication info: EP1756143 - 2007-02-28

ADOPTIVE IMMUNOCYTE FOR TUMOR VACCINE AND THE LIKE 6 in my patents list Inventor: HASUMI KENICHIRO (JP); IMAIZUMI AKIRA Applicant: SHUKOKAI INC (JP); CELAGIX RES LTD (JP)

(JP); (+2) EC: C12N5/00S IPC: C12N5/00; C12M3/00; C12N5/00 (+1)

Publication info: EP1757680 - 2007-02-28

INFLUENZA RECOMBINANT 7 in my patents list Inventor: WEEKS-LEVY CAROLYN (US); CLEMENTS Applicant: HAWAII BIOTECH INC (US); WEEKS-LEVY

DAVID E (US); (+1) CAROLYN (US); (+2) EC: IPC: A61K39/145; C07H21/04; C07K14/11 (+7)

Publication info: WO2007022425 - 2007-02-22

IMMUNIZATION OF AVIANS BY ADMINISTRATION OF NON-REPLICATING 8 VECTORED VACCINES in my patents list Inventor: TANG DE-CHU C (US); VAN KAMPEN KENT R Applicant: VAXIN INC (US); TANG DE-CHU C (US);

(US); (+1) (+2) EC: IPC: A61K48/00; A61K48/00

Publication info: WO2007022151 - 2007-02-22

AVIRULENT TROPHOZOITES OF ENTAMOEBA HISTOLYTICA FOR VACCINATION 9 AGAINST AMOEBIASIS in my patents list Inventor: BRACHA RIVKA (IL); NUCHAMOWITZ YAEL Applicant: YEDA RES & DEV (IL); BRACHA RIVKA (IL);

(IL); (+2) (+3) EC: IPC: C12N1/10; C12N1/10

Publication info: WO2007020633 - 2007-02-22

ANTIGENIC PEPTIDES AND THEIR USE 10 in my patents list Inventor: CORRADIN GIAMPIETRO (CH); KAJAVA Applicant: UNIV LAUSANNE (CH); PASTEUR INSTITUT

ANDREY (FR); (+2) (FR); (+4) EC: IPC:

Publication info: WO2007020520 - 2007-02-22

11 VACCINE BASED ON VIRUS-NEUTRALIZING ANTIBODIES in my patents list Inventor: DENNER JOACHIM (DE); LANGHAMMER STEFAN (DE); Applicant: BUNDESREP DEUTSCHLAND

(+2) (DE); DENNER JOACHIM (DE); (+3) EC: C07K16/10K1D; C07K14/16D IPC: C07K14/16; C07K16/10;

C07K19/00 (+7) Publication info: WO2007020243 - 2007-02-22

VACCINE 12 in my patents list Inventor: COLAU BRIGITTE DESIREE ALBERTE (BE); DE VOS Applicant: GLAXOSMITHKLINE BIOLOG BEATRICE ARSENE VIRGINI (BE) SA (BE); COLAU BRIGITTE DESIREE ALBERTE (BE); (+1) EC: IPC:

Publication info: WO2007020078 - 2007-02-22

COMPOSITION FOR BIRD IMMUNIZATION ADMINISTERED BY 13 AEROSOL in my patents list Inventor: RODRIGUEZ AGUIRRE JOSE FRANCIS (ES); ONA BLANCO Applicant: BIONOSTRA S L (ES); ANA MARIA (ES); (+2) RODRIGUEZ AGUIRRE JOSE FRANCIS (ES); (+3) EC: IPC: C12N7/04; A61K39/12; C07K14/08

(+3) Publication info: WO2007020017 - 2007-02-22

Antigen for developing neutralizing antibodies to human 14 immunodeficiency virus in my patents list Inventor: LU MIN (US); JI HONG (US) Applicant: CORNELL RES FOUNDATION

INC (US) EC: IPC: A61K39/21; A61K39/21

Publication info: US7179468 - 2007-02-20

West nile virus vaccine 15 in my patents list Inventor: KHROMYKH ALEXANDER A (AU); HALL ROY (AU) Applicant: UNIV QUEENSLAND (AU)

EC: IPC: A61K39/12; A61K39/193;

C12Q1/70 (+3) Publication info: US2007036827 - 2007-02-15

Hla-a24 binding cancer antigen peptide derived from livin 16 in my patents list Inventor: SATO NORIYUKI (JP); TORIGOE TOSHIHIKI (JP); (+2) Applicant:

EC: A61K38/17A2; A61K39/00D6; (+3) IPC: G01N33/574; A61K38/17;

A61K39/00 (+23) Publication info: US2007036812 - 2007-02-15

Therapeutic 17 in my patents list Inventor: STRATEN PER T (DK); ANDERSEN MADS H (DK) Applicant:

EC: IPC: A61K39/00; C07K7/08;

G01N33/574 (+3) Publication info: US2007036811 - 2007-02-15

Group b streptococcus vaccine 18 in my patents list Inventor: RAPPUOLI RINO (IT); TELFORD JOHN (IT); (+1) Applicant: CHIRON CORP (US)

EC: IPC: A61K39/08; C08B37/00;

A61K39/08 (+1) Publication info: US2007036828 - 2007-02-15

Influenza immunogen and vaccine 19 in my patents list Inventor: BIRKETT ASHLEY J (US); FIERS WALTER (BE) Applicant: APOVIA INC

EC: A61K39/145; C07K14/02; (+1) IPC: A61K39/395; A61K39/12;

A61K39/395 (+1) Publication info: US2007036826 - 2007-02-15

Tuberculosis antigen detection assays and vaccines 20 in my patents list Inventor: CAMPOS-NETO ANTONIO (US); KASHINO SUELY S (US) Applicant:

EC: IPC: A61K39/02; C07H21/04;

C07K14/35 (+9) Publication info: US2007036816 - 2007-02-15

21 Recombinant vaccine against botulinum neurotoxin in my patents list Inventor: SMITH LEONARD A (US); BYRNE MICHAEL P (US); (+4) Applicant:

EC: IPC: C07H21/04; C07K14/33; C12N1/21

(+5) Publication info: US2007037257 - 2007-02-15

22 Development of a live, attenuated, recombinant vaccine for in my patents list Inventor: BANDARA ALOKA B (US); BOYLE STEPHEN M (US); (+2) Applicant:

EC: IPC: A61K39/10; C12N1/21; A61K39/10

(+1) Publication info: US2007036823 - 2007-02-15

23 VACCINE FOR PERIODONTAL DISEASE in my patents list Inventor: DREIER KIMBERLY JEAN (US); HARDHAM JOHN MORGAN Applicant: PFIZER PROD INC (US)

(US); (+4) EC: A61K39/02C; A61K39/155; (+5) IPC: A61K39/02; A61K39/02

Publication info: EP1753454 - 2007-02-21

Vaccine composition 24 in my patents list Inventor: POOLMAN JAN; CAPIAU CARINE; (+3) Applicant: GLAXOSMITHKLINE BIOLOG

SA EC: IPC: A61K39/295; A61K39/095;

A61K39/102 (+17) Publication info: AU2007200116 - 2007-02-01

VIRUS-LIKE PARTICLES AS VACCINES FOR PARAMYXOVIRUS 25 in my patents list Inventor: MORRISON TRUDY G (US); PANTUA HOMER D (US) Applicant: UNIV MASSACHUSETTS MEDICAL (US); MORRISON TRUDY G (US); (+1) EC: IPC: A61K39/17; C12N15/86;

A61K39/155 (+1) Publication info: WO2007019247 - 2007-02-15

STABILIZERS FOR VETERINARY VACCINES 26 in my patents list Inventor: KUMAR MAHESH (US); RODENBERG JEFF H (US); (+2) Applicant: WYETH CORP (US); KUMAR

MAHESH (US); (+3) EC: IPC: A61K47/18; A61K47/42;

A61K47/16 (+1) Publication info: WO2007019128 - 2007-02-15

MODIFIED INFLUENZA VIRUS FOR MONITORING AND IMPROVING 27 VACCINE EFFICIENCY in my patents list Inventor: HOFFMANN ERICH (US); LIPATOV ALEKSANDR S (US); Applicant: ST JUDE CHILDRENS RES (+3) HOSPITAL (US); HOFFMANN ERICH (US); (+4) EC: IPC: A61K39/145; C07H21/04;

C07K14/11 (+7) Publication info: WO2007019094 - 2007-02-15

COMPOSITIONS AND METHODS FOR THE DETECTION OF HIV- 28 1/HIV-2 INFECTION in my patents list Inventor: GOLDING HANA (US); KHURANA SURENDER (US) Applicant: US HEALTH (US); GOLDING

HANA (US); (+1) EC: IPC: G01N33/50; G01N33/50

Publication info: WO2007018550 - 2007-02-15

ANTIGEN-AND-DRUG VEHICLE WHICH ENABLES THE CHANGEOVER 29 FROM THE SELECTIVE PRODUCTION OF IgA ANTIBODY TO THE PRODUCTION OF BOTH OF IgA AND IgG ANTIBODIES, AND in my patents list TRANSNASAL/TRANSMUCOSAL VACCINE USING THE VEHICLE Inventor: KIDO HIROSHI (JP); MIZUNO DAI (JP) Applicant: UNIV TOKUSHIMA (JP); KIDO

HIROSHI (JP); (+1) EC: IPC: A61K39/00; A61P37/08;

A61K39/00 (+1) Publication info: WO2007018152 - 2007-02-15

ANTIGEN CAPABLE OF INDUCING NEUTRALIZING ANTIBODY FOR 30 HIGH RISK-TYPE HUMAN PAPILLOMAVIRUS in my patents list Inventor: KANDA TADAHITO (JP); KONDO KAZUNARI (JP) Applicant: JAPAN HEALTH SCIENCES FOUNDATI (JP); KANDA TADAHITO (JP); (+1) EC: IPC: C07K14/025; C07K19/00;

C12N15/09 (+17) Publication info: WO2007018049 - 2007-02-15

31 Vaccine in my patents list Inventor: BOS MARTINE P (NL); POOLMAN JAN (BE); (+2) Applicant:

EC: A61K35/74; C07K14/22; (+1) IPC: A61K39/116; C07K14/22;

C07K14/315 (+4) Publication info: US2007031449 - 2007-02-08

32 Vaccine immunotherapy for immune suppressed patients in my patents list Inventor: HADDEN JOHN W (US) Applicant:

EC: IPC: A61K38/21; A61K31/192;

A61K31/415 (+9) Publication info: US2007031372 - 2007-02-08

33 Hcv vaccines in my patents list Inventor: BUSCHLE MICHAEL (GB); FRISCH JURGEN (DE); (+4) Applicant: INTERCELL AG (AT)

EC: A61K39/29; C07K14/18F4 IPC: A61K39/29; C07K14/18;

A61K39/00 (+3) Publication info: US2007031446 - 2007-02-08

34 Inactivating with hydrogen peroxide for vaccine production in my patents list Inventor: SLIFKA MARK K (US); CARTER SHIRLEY V (US); (+2) Applicant: UNIV OREGON

HEALTH & SCIENCE EC: IPC: A61K39/12; A61K33/40;

A61K39/02 (+3) Publication info: US2007031451 - 2007-02-08

Stabilizers for veterinary vaccines 35 in my patents list Inventor: KUMAR MAHESH (US); RODENBERG JEFF H (US); (+2) Applicant: WYETH CORP (US)

EC: IPC: C12Q1/68; A61K39/12;

C12Q1/68 (+1) Publication info: US2007031450 - 2007-02-08

Methods of vaccine administration, new feline caliciviruses, and treatments 36 for immunizing animals against feline paraovirus and feline herpes virus in my patents list Inventor: LOWERY DAVID E (US); RONG SING (US); (+4) Applicant:

EC: IPC: A61K39/125; A61K48/00;

A61K39/125 (+1) Publication info: US2007031454 - 2007-02-08

MODIFIED INFLUENZA VIRUS FOR MONITORING AND IMPROVING VACCINE 37 EFFICIENCY in my patents list Inventor: HOFFMANN ERICH (US); LIPATOV ALEKSANDR S (US); (+3) Applicant:

EC: IPC: A61K39/145; C07H21/04;

C07K14/11 (+7) Publication info: US2007031453 - 2007-02-08

Recombinant Vibrio cholerae strain and vaccine comprising said strain 38 in my patents list Inventor: FAVRE DIDIER (CH); DIETRICH GUIDO (CH); (+1) Applicant: BERNA BIOTECH AG

EC: C07K14/245; A61K39/02T1; (+1) IPC: A61K39/106; A61K9/00;

A61K39/02 (+9) Publication info: US2007031458 - 2007-02-08

Method for introducing and expressing genes in animal cells, and live 39 invasive bacterial vectors for use in the same in my patents list Inventor: POWELL ROBERT J (US); LEWIS GEORGE K (US); (+1) Applicant: UNIV MARYLAND

EC: IPC: A61K48/00; A61K39/02;

A61K48/00 (+1) Publication info: US2007031382 - 2007-02-08

Nipah virus vaccines 40 in my patents list Inventor: AUDONNET JEAN C F (FR) Applicant:

EC: IPC: A61K39/275; A61K39/285;

C12N15/86 (+2) Publication info: US2007031455 - 2007-02-08

41 Modified viral particles with immunogenic properties and reduced content useful for treating and preventing infectious in my patents list diseases Inventor: CHAM BILL E (AU) Applicant:

EC: IPC: C12Q1/68; C12P21/06; C12Q1/68

(+1) Publication info: US2007031923 - 2007-02-08

42 Immunotherapy based on dendritic cells in my patents list Inventor: COLLINS JOHN K (IE); O'MAHONY LIEM (IE) Applicant: ALIMENTARY HEALTH LTD

EC: A61K39/09; A61K39/02T3 IPC: A61K39/00; A61K39/02; A61K39/09

(+25) Publication info: US2007031441 - 2007-02-08

43 Vaccine comprising a tick cement protein in my patents list Inventor: TRIMNELL ADAMA R (GB); PAESEN GUIDO C (GB); Applicant: EVOLUTEC LTD

(+1) EC: A61K39/00C; C07K14/435A4A; (+1) IPC: A61K39/395; C12N15/09; A61K39/00

(+11) Publication info: US2007031411 - 2007-02-08

Modified Bacillus anthracis, vaccine compositions and methods of 44 use thereof in my patents list Inventor: DUBENSKY THOMAS W JR (US); PORTNOY DANIEL A Applicant:

(US); (+3) EC: IPC: A61K39/07; C12N1/21; A61K39/07

(+1) Publication info: US2007031457 - 2007-02-08

High throughput assays for transmissible spongiform 45 encephalopathies in my patents list Inventor: NISHIDA NORIYUKI (JP) Applicant: LAURA MANUELIDIS (US)

EC: G01N33/50D2; G01N33/50D2F4 IPC: C12N5/06; C12N5/10; C12N5/06 (+1)

Publication info: GB2429018 - 2007-02-14

RECOMBINANT LENTIVIRAL VECTOR FOR EXPRESSION OF A 46 FLAVIVIRIDAE PROTEIN AND APPLICATIONS THEREOF AS A in my patents list VACCINE Inventor: DESPRES PHILIPPE (FR); CHARNEAU PIERRE (FR); Applicant: PASTEUR INSTITUT (FR);

(+2) CENTRE NAT RECH SCIENT (FR) EC: C07K14/18; C12N15/867 IPC: C12N15/867; A61K39/12; A61K48/00

(+19) Publication info: EP1751291 - 2007-02-14

VACCINE COMPRISING AN ATTENUATED PESTIVIRUS 47 in my patents list Inventor: MEYERS GREGOR (DE); EGE ANDREAS (DE); (+2) Applicant: BOEHRINGER INGELHEIM

VETMED (DE) EC: C12N7/04; A61K39/12 IPC: C12N7/04; A61K39/00; A61K39/187

(+3) Publication info: EP1751276 - 2007-02-14

INFLUENZA VACCINE COMPOSITIONS AND METHODS OF USE 48 THEREOF in my patents list Inventor: SHNEIDER ALEXANDER M (US) Applicant: CURE LAB INC (US); SHNEIDER

ALEXANDER M (US) EC: IPC: A61K39/145; A61K39/145

Publication info: WO2007016598 - 2007-02-08

A METHOD OF TREATING CANCER CELLS TO CREATE A 49 MODIFIED CANCER CELL THAT PROVOKES AN IMMUNOGENIC in my patents list RESPONSE Inventor: KITABWALLA MOIZ (US); AKEEFE HASSIBULLAH (US) Applicant: LIPID SCIENCES INC (US);

KITABWALLA MOIZ (US); (+1) EC: IPC: A61K39/00; C12N5/06; A61K39/00

(+1) Publication info: WO2007016130 - 2007-02-08

NOVEL ATTENUATED VIRUS STRAINS AND USES THEREOF 50 in my patents list Inventor: WICKER JASON A (US); WHITEMAN MELISSA C (US); Applicant: RES DEV FOUNDATION (US);

(+1) WICKER JASON A (US); (+2) EC: IPC: C07K14/00; C07K14/00

Publication info: WO2007015783 - 2007-02-08

51 CYTOTOXIC T-CELL EPITOPE PEPTIDE AND USE THEREOF in my patents list Inventor: TOJI SHINGO (JP); KIM YOOL-JA (JP); (+1) Applicant: MEDICAL AND BIOLOG LAB CO

LTD (JP); TOJI SHINGO (JP); (+2) EC: IPC: C07K14/075; A61K38/00; A61K39/00

(+15) Publication info: WO2007015540 - 2007-02-08

52 METHOD OF TREATING PATIENTS WITH A MUCINOUS GLYCOPROTEIN (MUC-1) VACCINE in my patents list Inventor: LONGENECKER B MICHAEL (CA) Applicant: BIOMIRA INC (CA);

LONGENECKER B MICHAEL (CA) EC: IPC: A61K38/16; A61K9/127; A61P35/00

(+3) Publication info: WO2007015171 - 2007-02-08

53 REDUCING INTERFERENCE BETWEEN OIL-CONTAINING ADJUVANTS AND SURFACTANT-CONTAINING ANTIGENS in my patents list Inventor: CONTORNI MARIO (IT) Applicant: NOVARTIS VACCINES AND

DIAGNOST (IT); CONTORNI MARIO (IT) EC: IPC: A61K39/00; A61K39/00

Publication info: WO2007015167 - 2007-02-08

54 HELMINTH ANTIGEN AND IMMUNOTHERAPY in my patents list Inventor: LOUKAS ALEXANDER CONSTANTINE (AU); TRAN MAI Applicant: QUEENSLAND INST MED RES (AU); (+5) (AU); LOUKAS ALEXANDER CONSTANTINE (AU); (+6) EC: IPC: C07K14/435; A61K48/00; A61P33/12

(+9) Publication info: WO2007014415 - 2007-02-08

55 in my patents list Inventor: ROBERTS DAVID S (US); SWEARINGIN LEROY A (US); Applicant: PFIZER (US)

(+1) EC: IPC: A61K39/02; A01N63/00; A61K39/00

(+3) Publication info: US7172762 - 2007-02-06

COMPOSITIONS AND METHODS FOR ENHANCING IMMUNITY BY 56 CHEMOATTRACTANT ADJUVANTS in my patents list Inventor: PREMACK BRETT (US); WALTERS MATTHEW J (US); Applicant: CHEMOCENTRYX INC (US)

(+1) EC: IPC: A61K39/39; A61K31/00; A61K31/70

(+17) Publication info: CA2555410 - 2007-02-03

Vaccine composition comprising il-12 adjuvant encapsulated in 57 controlled-release microsphere in my patents list Inventor: SUNG YOUNG C (KR); PARK SU H (KR); (+5) Applicant:

EC: A61K39/39 IPC: A61K39/00; A61K39/39; A61K39/00

(+1) Publication info: US2007026005 - 2007-02-01

Molecular vaccines employing nucleic acid encoding anti- 58 apoptotic proteins in my patents list Inventor: WU TZYY-CHOOU (US); HUNG CHIEN F (US); (+1) Applicant:

EC: IPC: A61K48/00; A61K9/14; C12N15/09

(+5) Publication info: US2007026076 - 2007-02-01

DNA vaccines encoding antigen linked to a domain that binds 59 CD40 in my patents list Inventor: LEDBETTER JEFFREY A (US); HAYDEN-LEDBETTER Applicant: TRUBION PHARMACEUTICALS

MARTHA (US) (US) EC: IPC: A61K39/395; A61K39/12; A61K39/395

(+1) Publication info: US2007025982 - 2007-02-01

Method of treating cancer cells to create a modified cancer cell 60 that provokes an immunogenic response in my patents list Inventor: KITABWALLA MOIZ (US); AKEEFE HASSIBULLAH (US) Applicant:

EC: IPC: A61K39/00; C12N5/06; A61K39/00

(+1) Publication info: US2007026006 - 2007-02-01

61 Vaccine immunotherapy in my patents list Inventor: HADDEN JOHN W (US) Applicant:

EC: IPC: A61K38/21; A61K38/19; A61K38/20

(+3) Publication info: US2007025958 - 2007-02-01

62 Dengue serotype 2 attenuated strain in my patents list Inventor: KINNEY RICHARD (US); HUANG CLAIRE Y (US); (+3) Applicant:

EC: IPC: A61K39/12; A61K39/193; C07H21/04

(+9) Publication info: US2007026016 - 2007-02-01

63 Vaccine-induced hepatitis B viral strain and uses thereof in my patents list Inventor: OON CHONG J (SG); LIM GEK K (SG); (+3) Applicant: GOVERNMENT OF THE REPUBLIC

OF EC: C12Q1/70B6 IPC: C12Q1/68; G01N33/53; C12Q1/68

(+1) Publication info: US2007026422 - 2007-02-01

Modified mycobacterium tuberculosis strains and uses thereof 64 in my patents list Inventor: ERNST JOEL D (US); BANAIEE NIAZ (US) Applicant:

EC: IPC: A61K39/04; C12N1/21; G01N33/554

(+3) Publication info: US2007026020 - 2007-02-01

Coccidial vaccine and methods of making and using same 65 in my patents list Inventor: MCDOUGALD LARRY R (US); FULLER ALBERTA L (US); Applicant:

(+1) EC: IPC: A61K39/012; A61K39/002

Publication info: US2007026023 - 2007-02-01

METHODS OF VACCINE ADMINISTRATION, NEW FELINE 66 CALICIVIRUSES, AND TREATMENTS FOR IMMUNIZING ANIMALS in my patents list AGAINST FELINE PARAOVIRUS AND FELINE HERPES VIRUS Inventor: LOWERY DAVID EARL (US); RONG SING (US); (+4) Applicant: PFIZER PROD INC (US); LOWERY

DAVID EARL (US); (+5) EC: IPC: A61K38/16; A61K39/12; A61K48/00

(+9) Publication info: WO2007012944 - 2007-02-01

Revista Vaccine

Tabla de Contenidos. Volume 25, Issue 11, Pages 1921 – 2160 (1 March 2007).

1. Editorial Board Page CO2

Letter to the Editor

2. Pre-emptive vaccination against pandemic influenza virus Pages 1921-1922 Emanuele Montomoli and Ilaria Manini

Reviews

3. Status and challenges of filovirus vaccines Pages 1923-1934 Douglas S. Reed and Mansour Mohamadzadeh 4. The epidemiology of pneumococcal, meningococcal, and Haemophilus disease in the Middle East and North Africa (MENA) Region—Current status and needs Pages 1935-1944 William P. Hausdorff, Rana Hajjeh, Abdulrahman Al-Mazrou, Atef Shibl and Montse Soriano-Gabarro

Regular papers

5. Parental attitudes to pre-pubertal HPV vaccination Pages 1945-1952 Laura A.V. Marlow, Jo Waller and Jane Wardle 6. Kinetics of the immune response following pneumococcal PD conjugate vaccination Pages 1953-1961 Lode Schuerman, Roman Prymula, Viktor Chrobok, Ilse Dieussaert and Jan Poolman 7. ELISA IgG concentrations and opsonophagocytic activity following pneumococcal protein D conjugate vaccination and relationship to efficacy against acute otitis media Pages 1962-1968 Lode Schuerman, Roman Prymula, Isabelle Henckaerts and Jan Poolman 8. Generation and immunogenicity of novel HIV/AIDS vaccine candidates targeting HIV-1 Env/Gag-Pol-Nef antigens of clade C Pages 1969-1992 Carmen Elena Gómez, Jose Luis Nájera, Victoria Jiménez, Kurt Bieler, Jens Wild, Linda Kostic, Shirin Heidari, Margaret Chen, Marie-Joelle Frachette, Giuseppe Pantaleo, Hans Wolf, Peter Liljeström, Ralf Wagner and Mariano Esteban 9. Comparative analysis of new innovative vaccine formulations based on the use of procaryotic display systems Pages 1993-2000 Luciana D’Apice, Rossella Sartorius, Antonella Caivano, Dina Mascolo, Giovanna Del Pozzo, Donatella Scotto Di Mase, Ezio Ricca, Giuseppina Li Pira, Fabrizio Manca, Donatella Malanga, Raffaele De Palma and Piergiuseppe De Berardinis 10. A papillomavirus-like particle (VLP) vaccine displaying HPV16 L2 epitopes induces cross- neutralizing antibodies to HPV11 Pages 2001-2010 Katharina Slupetzky, Ratish Gambhira, Timothy D. Culp, Saeed Shafti-Keramat, Christina Schellenbacher, Neil D. Christensen, Richard B.S. Roden and Reinhard Kirnbauer 11. A Francisella tularensis subspecies novicida purF mutant, but not a purA mutant, induces protective immunity to tularemia in mice Pages 2011-2018 J.E. Quarry, K.E. Isherwood, S.L. Michell, H. Diaper, R.W. Titball and P.C.F Oyston 12. Rationing of influenza vaccine during a pandemic: Ethical analyses Pages 2019-2026 Richard Kent Zimmerman 13. Babesia gibsoni ribosomal phosphoprotein P0 induces cross-protective immunity against B. microti infection in mice Pages 2027-2035 M. Alaa Terkawi, Honglin Jia, Jinlin Zhou, Eung-goo Lee, Ikuo Igarashi, Kozo Fujisaki, Yoshifumi Nishikawa and Xuenan Xuan 14. B cell mediated priming following pneumococcal colonization Pages 2036-2042 Bradley Rabquer, Anne K. Shriner, S. Louise Smithson and M.A. Julie Westerink 15. Long-lasting specific antibodies against P277 induced by mucosal administration of P277 repeat sequences carried by Hsp65 in the absence of adjuvants Pages 2043-2050 Liang Jin, Yu Wang, Qiyan Xiong, Qingmei Chen, Jianping Li, Aihua Zhu, Rongyue Cao, Jie Wu and Jingjing Liu 16. Effect of immunisation against gonadotrophin releasing hormone isoforms (mammalian GnRH-I, chicken GnRH-II and lamprey GnRH-III) on murine spermatogenesis Pages 2051-2063 Mohammad A.H. Khan, Martine Prevost, Mary M. Waterston, Michael J.A. Harvey and Valerie A. Ferro 17. Electric pulses applied prior to intramuscular DNA vaccination greatly improve the vaccine immunogenicity Pages 2064-2073 Baowei Peng, Yonggang Zhao, Lingyun Xu and Yuhong Xu 18. Novel vectors based on the enteric-tropic serotype 41 Pages 2074-2084 Franck Lemiale, Hedi Haddada, Gary J. Nabel, Douglas E. Brough, C. Richter King and Jason G.D. Gall 19. Chitosan solution enhances both humoral and cell-mediated immune responses to subcutaneous vaccination Pages 2085-2094 David A. Zaharoff, Connie J. Rogers, Kenneth W. Hance, Jeffrey Schlom and John W. Greiner 20. Immunological characterization of a bacterial protein isolated from salmonid fish naturally infected with Piscirickettsia salmonis Pages 2095-2102 Sergio H. Marshall, Pablo Conejeros, Marcela Zahr, Jorge Olivares, Fernando Gómez, Patricio Cataldo and Vitalia Henríquez 21. Prophylactic potential of liposomized integral membrane protein of Plasmodium yoelii nigeriensis against blood stage infection in BALB/c mice Pages 2103-2111 Sharad Kumar Sharma, Chittarmal Gupta, Varun Dwivedi, Shailja Misra-Bhattacharya and Owais Mohammad 22. Construction and evaluation of a multistage combination vaccine against malaria Pages 2112-2119 Qingfeng Zhang, Xiangyang Xue, Li Qu and Weiqing Pan 23. Studies of a prophylactic HIV-1 vaccine candidate based on modified vaccinia virus Ankara (MVA) with and without DNA priming: Effects of dosage and route on safety and immunogenicity Pages 2120-2127 Barry S. Peters, Walter Jaoko, Eftyhia Vardas, George Panayotakopoulos, Patricia Fast, Claudia Schmidt, Jill Gilmour, Mampedi Bogoshi, Gloria Omosa-Manyonyi, Len Dally, Linda Klavinskis, Bashir Farah, Tony Tarragona, Pierre-Alexandre Bart, Andrew Robinson, Colleen Pieterse, Wendy Stevens, Richard Thomas, Burc Barin, Andrew J. McMichael, James A. McIntyre, Giuseppe Pantaleo, Tomáš Hanke and Job Bwayo 24. Prime-boost immunization with DNA, recombinant fowlpox virus and VLPSHIV elicit both neutralizing antibodies and IFNγ-producing T cells against the HIV-envelope protein in mice that control env-bearing tumour cells Pages 2128-2138 Antonia Radaelli, Olivia Bonduelle, Paola Beggio, Brice Mahe, Eleana Pozzi, Veronica Elli, Manuela Paganini, Carlo Zanotto, Carlo De Giuli Morghen and Béhazine Combadière 25. Safety and immunogenicity of a in varicella-zoster virus seronegative and low-seropositive healthy adults Pages 2139-2144 N. Macaladad, T. Marcano, M. Guzman, J. Moya, F. Jurado, M. Thompson, C. Meechan, D. Li, K. Schlienger, I. Chan, J. Sadoff, F. Schödel and J.L. Silber 26. Evaluation of immunogenicity and efficacy of combined DNA and adjuvanted protein vaccination in a human immunodeficiency virus type 1/murine leukemia virus pseudotype challenge model Pages 2145-2154 Erik Rollman, Nathalie Mathy, Andreas Bråve, Andreas Boberg, Anne Kjerrström, Cathy van Wely, Gunnel Engström, Susanne Johansson, Kajsa Aperia, Lars E. Eriksson, Reinhold Benthin, Peter Ertl, Jonathan Heeney, Jorma Hinkula, Gerald Voss and Britta Wahren 27. Chapter III. The Second European Influenza Conference: lessons learnt and actions to take. The urgent need for a European Influenza Task Force Pages 2155-2160

Emerging Infectious Diseases

Tabla de Contenidos. Volume 13, Number 3, March 2007).

Abbreviated table of contents:

PERSPECIVE

Bird Migration Routes and Risk for Dispersion into Western Mediterranean Wetlands, E. Jourdain et al. http://www.cdc.gov/eid/content/13/3/365.htm?s_cid=eid365_e

SYNOPSIS

Human and Animal Vaccination Campaigns, Chad, E. Schelling et al. http://www.cdc.gov/eid/content/13/3/373.htm?s_cid=eid373_e

RESEARCH

Worldwide Emergence of Extensively Drug-resistant Tuberculosis, N.S. Shah et al. http://www.cdc.gov/eid/content/13/3/380.htm?s_cid=eid380_e

Behavioral Risks for West Nile Virus Disease, Northern Colorado, I.B. Gujral et al. http://www.cdc.gov/eid/content/13/3/419.htm?s_cid=eid419_e

Matrix Protein 2 Vaccination and Protection against Influenza Viruses, S.M. Tompkins et al. http://www.cdc.gov/eid/content/13/3/426.htm?s_cid=eid426_e

Surveillance of Influenza A Virus in Migratory Waterfowl, A. Wallensten et al. http://www.cdc.gov/eid/content/13/3/404.htm?s_cid=eid404_e

Surveillance of Human Salmonella Typhimurium Infections, M. Torpdahl et al. http://www.cdc.gov/eid/content/13/3/388.htm?s_cid=eid388_e

Diversity and Distribution of Borrelia hermsii, T.G. Schwan et al. http://www.cdc.gov/eid/content/13/3/436.htm?s_cid=eid436_e

In Vitro Cell Culture Infectivity Assay for Human Noroviruses, T.M. Straub et al. http://www.cdc.gov/eid/content/13/3/396.htm?s_cid=eid396_e

Population-based Laboratory Surveillance for AmpC beta-Lactamase-producing , Calgary, J.D.D. Pitout et al. http://www.cdc.gov/eid/content/13/3/443.htm?s_cid=eid443_e

Risk for Infection with Highly Pathogenic Influenza A Virus (H5N1) in Chickens, Hong Kong, 2002, N.Y. Kung et al. http://www.cdc.gov/eid/content/13/3/412.htm?s_cid=eid412_e

Effectiveness of Neuraminidase Inhibitors for Preventing Staff Absenteeism during Pandemic Influenza, V.J. Lee and M.I. Chen http://www.cdc.gov/eid/content/13/3/449.htm?s_cid=eid449_e

DISPATCHES

Environmental Burkholderia cepacia Complex Isolates, A. Baldwin et al. http://www.cdc.gov/eid/content/13/3/458.htm?s_cid=eid458_e

Mouse-to-Human Transmission of Variant Lymphocytic Choriomeningitis Virus, S. Emonet et al. http://www.cdc.gov/eid/content/13/3/472.htm?s_cid=eid472_e

Cryptosporidium hominis Infection of the Human Respiratory Tract, R. Mercado et al. http://www.cdc.gov/eid/content/13/3/462.htm?s_cid=eid462_e

Leishmania donovani and Cutaneous , Sri Lanka, H.V.Y.D. Siriwardana et al. http://www.cdc.gov/eid/content/13/3/476.htm?s_cid=eid476_e

Depression after West Nile Virus Infection, K.O. Murray et al. http://www.cdc.gov/eid/content/13/3/479.htm?s_cid=eid479_e

Detection of G12 Human Rotaviruses in Nepal, S.B. Pun et al. http://www.cdc.gov/eid/content/13/3/482.htm?s_cid=eid482_e

Clostridium difficile in Ground Meat, Canada, A. Rodriguez-Palacios et al. http://www.cdc.gov/eid/content/13/3/485.htm?s_cid=eid485_e

Methicillin-susceptible, Doxycycline-resistant Staphylococcus aureus, Cote d'Ivoire, O. Lesens et al. http://www.cdc.gov/eid/content/13/3/488.htm?s_cid=eid488_e

Intermediate Vancomycin Susceptibility in MRSA, C.J. Graber et al. http://www.cdc.gov/eid/content/13/3/491.htm?s_cid=eid491_e

Staphylococcal Cassette Chromosome mec in MRSA, Taiwan, J.-T. Wang et al. http://www.cdc.gov/eid/content/13/3/494.htm?s_cid=eid494_e

Cocirculation of 2 Toscana Virus Genotypes, France, R.N. Charrel et al. http://www.cdc.gov/eid/content/13/3/465.htm?s_cid=eid465_e

Clostridium difficile-associated Disease in New Jersey Hospitals, 2000-2004, E.T. Tan et al. http://www.cdc.gov/eid/content/13/3/498.htm?s_cid=eid498_e

Acanthamoeba Encephalitis and Cryoglobulinemia, W. Meersseman et al. http://www.cdc.gov/eid/content/13/3/469.htm?s_cid=eid469_e

LETTERS

Avian Influenza A (H5N1) Age Distribution in Humans, M. Smallman-Raynor and A.D. Cliff http://www.cdc.gov/eid/content/13/3/510.htm?s_cid=eid510_e

Drug-resistant Nontyphoidal Salmonella Bacteremia, W. Kulwichit et al. http://www.cdc.gov/eid/content/13/3/501.htm?s_cid=eid501_e

Fulminant Supraglottitis from Neisseria meningitidis, M.G. Kortepeter et al. http://www.cdc.gov/eid/content/13/3/502.htm?s_cid=eid502_e

Fluoroquinolone Resistance in Clostridium difficile PCR-027, D. Drudy et al. http://www.cdc.gov/eid/content/13/3/504.htm?s_cid=eid504_e

New Strain of Influenza A (H5N1), Thailand, S. Chutinimitkul et al. http://www.cdc.gov/eid/content/13/3/506.htm?s_cid=eid506_e

Kala-azar Control, Uganda, J.H. Kolaczinski et al. http://www.cdc.gov/eid/content/13/3/507.htm?s_cid=eid507_e

Chikungunya Virus Infection, Australia, J.D. Druce et al. http://www.cdc.gov/eid/content/13/3/509.htm?s_cid=eid509_e

Toxoplasma gondii, Brazil (Replies) http://www.cdc.gov/eid/content/13/3/512.htm?s_cid=eid512_e

CTX-M Extended-spectrum beta-Lactamase, Washington State, S. Kim et al. http://www.cdc.gov/eid/content/13/3/513.htm?s_cid=eid513_e

HIV and Hepatitis C Virus Coinfection, Cameroon, C. Laurent et al. http://www.cdc.gov/eid/content/13/3/514.htm?s_cid=eid514_e

Amebic Liver Abscess in HIV-infected Patients, W.B. Park et al. http://www.cdc.gov/eid/content/13/3/516.htm?s_cid=eid516_e

Pregnancy and Emerging Diseases (Replies) http://www.cdc.gov/eid/content/13/3/518.htm?s_cid=eid518_e

Escherichia coli Cluster Evaluation, J.R. Johnson http://www.cdc.gov/eid/content/13/3/520A.htm?s_cid=eid520A_e

Novel Hantavirus Sequences in Shrew, Guinea, B. Klempa et al. http://www.cdc.gov/eid/content/13/3/520B.htm?s_cid=eid520B_e

MEDIA REVIEW

Biodefense: Research Methodology and Animal Models, K. Taylor http://www.cdc.gov/eid/content/13/3/523.htm?s_cid=eid523_e

NEWS AND NOTES

Etymology http://www.cdc.gov/eid/content/13/3/403.htm?s_cid=eid403_e

Corrections http://www.cdc.gov/eid/content/13/3/522.htm?s_cid=eid522_e

ABOUT THE COVER

The Way Forward Is the Way Back, P. Potter http://www.cdc.gov/eid/content/13/3/524.htm?s_cid=eid524_e